GRACEcast
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
Visit Show Website http://cancerGRACE.org/Recently Aired
-
HD
The Best Thing You Can Do As a Kidney Cancer Patient
Dr. Daniel Heng has advice to kidney cancer patients who ...
Dr. Daniel Heng has advice to kidney cancer patients who want the best treatment for their disease. To find a clinical trial that is right for you, visit clinicaltrials.gov and enter "kidney cancer" in the search box.
-
HD
RADIANT and SELECT: Is Adjuvant Erlotinib Effective in Early-Stage Lung Cancer?
Drs. Nasser Hanna and Melissa Johnson discuss new trial evidence ...
Drs. Nasser Hanna and Melissa Johnson discuss new trial evidence for the use of adjuvant Eroltinib for early-stage lung cancer.
-
HD
Are There PD1 Biomarkers in Kidney Cancer?
Predictive biomarkers can indicate if a patient will respond to ...
Predictive biomarkers can indicate if a patient will respond to a particular therapy. Dr. Lauren Harshman discusses if researchers know of any biomarkers for kidney cancer patients taking PD1 inhibitor drugs.
-
HD
Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy?
Dr. Nasser Hanna outlines the possible benefits of consolidation chest ...
Dr. Nasser Hanna outlines the possible benefits of consolidation chest radiation for small cell lung cancer patients who respond well to chemotherapy.
-
HD
Management of Rare Kidney Tumors
What puts you at risk for inherited kidney cancer? Dr. ...
What puts you at risk for inherited kidney cancer? Dr. Nizar Tannir discusses the signs doctors look for to determine if a kidney cancer patient should be screened for a familial syndrome.
-
HD
Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation?
The doctors discuss the circumstances under which small cell lung ...
The doctors discuss the circumstances under which small cell lung cancer patients should receive prophylactic cranial irradiation.
-
HD
NanoString Treatment for Kidney Cancer
NanoString Technology may help doctors learn what is driving tumor ...
NanoString Technology may help doctors learn what is driving tumor growth in kidney cancer patients and, therefore, determine what treatments may be most effective for them.
-
HD
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer?
Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR ...
Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.
-
HD
How is the Heng Criteria Applied to Kidney Cancer Patients?
Dr. Daniel Heng is the namesake of the Heng Criteria, ...
Dr. Daniel Heng is the namesake of the Heng Criteria, which evaluates various factors of kidney cancer patients to determine their prognoses.
-
HD
Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment?
The REVEL trial studied 1,200 non-small cell lung cancer patients ...
The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had mixed feelings about the results.
